Literature DB >> 32674597

Interdigital Commissural Approach for Morton's Neuroma.

Juan Manuel Yañez Arauz1.   

Abstract

BACKGROUND: Morton's neuroma is a frequent cause of metatarsalgia. Operative treatment is indicated if nonoperative management has failed. The objective of the present study was to describe a technique of Morton's neuroma excision by a minimally invasive commissural approach and evaluate the long-term outcome and complications.
METHODS: A retrospective study of 108 patients with Morton's neuroma treated surgically with a commissural approach between September 1990 and December 2010 was performed. The surgical technique is described. Clinical outcomes and complications were evaluated. The average follow-up was 121 months. Eleven patients were men and 97 women. The average age was 49.4 years; 56.8% neuromas were at the third space and 43.2% at the second space. Six patients presented 2 neuromas in the same foot, and 9 patients had bilateral neuroma.
RESULTS: The visual analog scale (VAS) average pain score was 5.4 points preoperatively and 0.2 points at the final follow-up. The author found a significant difference between the VAS scores preoperatively and postoperatively (P < .01). Excellent and good satisfaction outcomes were achieved in 93.6%. The postoperative complication incidence was 3%.
CONCLUSION: The author believes a minimally invasive commissural approach has advantages over a dorsal or plantar incision. It is a simple and reproducible technique, with satisfactory outcomes, low complication rates, and a quick return to usual activities. LEVEL OF EVIDENCE: Level IV, retrospective case series.

Entities:  

Keywords:  Morton neuroma; commissural approach; interdigital neuroma; metatarsalgia; minimally invasive surgery

Mesh:

Year:  2020        PMID: 32674597     DOI: 10.1177/1071100720936599

Source DB:  PubMed          Journal:  Foot Ankle Int        ISSN: 1071-1007            Impact factor:   2.827


  1 in total

1.  Plantar and dorsal approaches for excision of morton's neuroma: a comparison study.

Authors:  Wenpeng Xu; Ning Zhang; Zhengxun Li; Yifan Wang; Xiucun Li; Yang Wang; Haipeng Si; Yong Hu
Journal:  BMC Musculoskelet Disord       Date:  2022-10-06       Impact factor: 2.562

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.